Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Dana-Farber, University of Texas, VU University Amsterdam

Premium

Title: Methods of Treating Meiotic Kinesin-associated Disease

Patent Number: 8,629,118

Filed: April 7, 2011

Inventor: David Pellman, Dana-Farber Cancer Institute


Title: Dual Targeting of miR-208 and miR-499 in the Treatment of Cardiac Disorders

Patent Number: 8,629,119

Filed: Feb. 4, 2010

Lead Inventor: Eric Olson, University of Texas (Miragen Therapeutics)


Title: Plant Nucleic Acids Associated with Cellular pH and Uses Thereof

Patent Number: 8,629,258

Filed: June 4, 2009

Lead Inventor: Francesca Quattrocchio, VU University Amsterdam

The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.